Yüklüyor......
A Severe Case of Cutaneous Adverse Drug Reaction Secondary to a Novice Drug: Idelalisib
Phosphatidylinositol 3-kinase δ (PIK3δ) is a tyrosine kinase essential for B cell survival, making it an important target in the treatment of chronic lymphocytic leukemia. Idelalisib is an inhibitor of PIK3δ demonstrating initial success in disease response, but is now shown to have a decreased over...
Kaydedildi:
| Yayımlandı: | J Investig Med High Impact Case Rep |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5446100/ https://ncbi.nlm.nih.gov/pubmed/28589155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709617711463 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|